Pharmagen Inc (PHRX)
0.00
USD |
OTCM |
Apr 25, 16:00
Pharmagen Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 5.158M |
| April 24, 2024 | 5.158M |
| April 23, 2024 | 5.158M |
| April 22, 2024 | 5.158M |
| April 19, 2024 | 5.158M |
| April 18, 2024 | 5.158M |
| April 17, 2024 | 5.158M |
| April 16, 2024 | 5.158M |
| April 15, 2024 | 5.158M |
| April 12, 2024 | 5.158M |
| April 11, 2024 | 5.158M |
| April 10, 2024 | 5.158M |
| April 09, 2024 | 5.158M |
| April 08, 2024 | 5.158M |
| April 05, 2024 | 5.158M |
| April 04, 2024 | 5.158M |
| April 03, 2024 | 5.158M |
| April 02, 2024 | 5.158M |
| April 01, 2024 | 5.158M |
| March 28, 2024 | 5.158M |
| March 27, 2024 | 5.158M |
| March 26, 2024 | 5.158M |
| March 25, 2024 | 5.158M |
| March 22, 2024 | 5.158M |
| March 21, 2024 | 5.158M |
| Date | Value |
|---|---|
| March 20, 2024 | 5.158M |
| March 19, 2024 | 5.158M |
| March 18, 2024 | 5.158M |
| March 15, 2024 | 5.158M |
| March 14, 2024 | 5.158M |
| March 13, 2024 | 5.158M |
| March 12, 2024 | 5.158M |
| March 11, 2024 | 5.158M |
| March 08, 2024 | 5.158M |
| March 07, 2024 | 5.158M |
| March 06, 2024 | 5.158M |
| March 05, 2024 | 5.158M |
| March 04, 2024 | 5.158M |
| March 01, 2024 | 5.158M |
| February 29, 2024 | 5.158M |
| February 28, 2024 | 5.158M |
| February 27, 2024 | 5.158M |
| February 26, 2024 | 5.158M |
| February 23, 2024 | 5.158M |
| February 22, 2024 | 5.158M |
| February 21, 2024 | 5.158M |
| February 20, 2024 | 5.158M |
| February 16, 2024 | 5.158M |
| February 15, 2024 | 5.158M |
| February 14, 2024 | 5.158M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.158M
Minimum
Nov 01 2022
6.063M
Maximum
Feb 12 2021
5.327M
Average
5.210M
Median
Jun 04 2021
Enterprise Value Benchmarks
| Cross Country Healthcare Inc | 587.13M |
| CEL-SCI Corp | 75.03M |
| AIM ImmunoTech Inc | 7.904M |
| IGC Pharma Inc | 26.17M |
| NovaBay Pharmaceuticals Inc | 2.275M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.7126M |
| Revenue (Quarterly) | 1.320M |
| Total Expenses (Quarterly) | 1.73M |